Sumalpong, Tata Eldie E.
HRN: 25-69-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/17/2024
08/24/2024
IV
600mg
Q8
Nonhealing Wound
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes